OPENoncology Profile Banner
Open Oncology Profile
Open Oncology

@OPENoncology

Followers
2K
Following
17K
Statuses
1K

Just the latest in oncology. What's axiomatic and what's problematic. 💯 #MedTwitter

New York, NY
Joined December 2016
Don't wanna be here? Send us removal request.
@OPENoncology
Open Oncology
4 days
RT @medicalwatchBC: Patient organoids in #RCC, H/T: @organoidscience
0
4
0
@OPENoncology
Open Oncology
5 days
RT @jgong15: Today is #WorldCancerDay thank you @KTLA for this interview & raising cancer awareness @LuParker @glenwalkerktla @CSCancerCe
0
17
0
@OPENoncology
Open Oncology
5 days
RT @medicalwatchBC: Hairy cell leukemia, H/T: @smbenlazar
0
6
0
@OPENoncology
Open Oncology
6 days
RT @medicalwatchBC: Happy Monday everyone! Here's the Top Post of the Week 🎉🎉🎉 Coming from our friend @StephenVLiu on a talk by @JordiRemo
0
5
0
@OPENoncology
Open Oncology
9 days
RT @medicalwatchBC: Many thanks to @Larvol for a terrific initiative honoring oncologists on Twitter/X ❤️ We appreciate you! 👏👏👏
0
3
0
@OPENoncology
Open Oncology
10 days
RT @medicalwatchBC: Renal cell carcinoma, H/T: @ziad_zaatari
0
7
0
@OPENoncology
Open Oncology
14 days
RT @jgong15: Repurposing of aspirin for prevention of #CRC recurrence. If you like to know more about the history of aspirin in #CRC chemop…
0
16
0
@OPENoncology
Open Oncology
15 days
RT @jgong15: @AasmaShaukatMD PREEMPT CRC study of @freenome blood-based screening test of advanced colorectal neoplasia (ACN) ➡️ #CRC sensi…
0
8
0
@OPENoncology
Open Oncology
15 days
RT @ArndtVogel: Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer @NEJM 👉3 yrs PFS…
0
28
0
@OPENoncology
Open Oncology
15 days
RT @medicalwatchBC: Announcing the Top Post of #GI25 Day 3 🎉🎉🎉 Coming from our friend @ShaalanBeg on pan-RAS inhibitors coming to the clin…
0
3
0
@OPENoncology
Open Oncology
15 days
RT @medicalwatchBC: @OncBrothers rockin' the stage with the legendary @marklewismd and @rutikamehtaMD! 🔥🔥🔥
Tweet media one
0
5
0
@OPENoncology
Open Oncology
15 days
RT @jgong15: Dr. Picozzi @PanCAN Precision Promise #1L gem/abraxane + pamrevlumab (anti-CCN2 ab) vs GA alone in met #PDAC ➡️ innovative pla…
0
6
0
@OPENoncology
Open Oncology
15 days
RT @jgong15: STARTER-NET rand PhIII of 1:1 everolimus + lanreotide vs evero alone in #1L G1/2 adv #GEP-NET ➡️ sig improved median PFS (29.7…
0
13
0
@OPENoncology
Open Oncology
16 days
RT @medicalwatchBC: Announcing the Top Post of #GI25 Day 2 🎉🎉🎉 Coming from our friend @marklewismd on biomarker testing in GI cancer:
0
4
0
@OPENoncology
Open Oncology
16 days
RT @RenoHemonc: @VPrasadMDMPH Disparity research and DEI are good for starting careers without putting much effort. Once you are a design…
0
4
0
@OPENoncology
Open Oncology
16 days
RT @ehlJAMA: @VPrasadMDMPH For years, when I was an editor at JAMA, I told authors don’t send me papers showing that disparities exist. We…
0
12
0
@OPENoncology
Open Oncology
16 days
RT @medicalwatchBC: Announcing the Top Post of #GI25 Day 1 🎉🎉🎉 Coming from our friends at @TumorBoardTues on a discussion on refractory me…
0
5
0
@OPENoncology
Open Oncology
16 days
RT @ankurnagpal: Wouldn't it be nice if paying taxes in America was logging on to a website that told you how much you owed & paying that a…
0
18
0
@OPENoncology
Open Oncology
17 days
RT @jgong15: Single-arm PhII trial of camrelizumab (PD-1 inh) + nab-paclitaxel, oxaliplatin, fluoro in unresectable or limited met #G/GEJ a…
0
9
0
@OPENoncology
Open Oncology
17 days
@AaronGoodman33 If the federal government was efficiently run, we could significantly reduce the income tax burden for all citizens including our most vulnerable. We have a spending problem, not a revenue problem.
0
0
0